Rocket One Inc. Depreciation
Rocket One Inc. (RKTO) reported Depreciation of $1.04 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2022-03-30
- Rocket One Inc. depreciation for the quarter ending 2020-12-31 was $124.00, a 59.87% decline year-over-year.
- Rocket One Inc. depreciation for the quarter ending 2020-09-30 was $309.00, a 0.32% increase year-over-year.
- Rocket One Inc. depreciation for the quarter ending 2020-06-30 was $305.00, a 0.33% decline year-over-year.
- Rocket One Inc. depreciation for the quarter ending 2020-03-31 was $305.00, a 0.99% increase year-over-year.
- Rocket One Inc. depreciation for fiscal 2020 was $1.04K, a 14.86% decline from fiscal 2019.
- Rocket One Inc. depreciation for fiscal 2019 was $1.23K, a 0.08% increase from fiscal 2018.
- Rocket One Inc. depreciation for fiscal 2018 was $1.22K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 8 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | $124.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $433.00 derived: sum of 2 quarters · filed 2022-03-30 | $738.00 derived: sum of 3 quarters · filed 2022-03-30 | $1.04K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $309.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $614.00 derived: sum of 2 quarters · filed 2021-11-10 | $919.00 10-Q · filed 2021-11-10 | $1.23K derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $305.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $610.00 10-Q · filed 2021-08-11 | $919.00 derived: sum of 3 quarters · filed 2021-08-11 | $1.23K derived: sum of 4 quarters · filed 2021-08-11 | |
| 2020-03-31 | $305.00 10-Q · filed 2021-05-13 | $614.00 derived: sum of 2 quarters · filed 2021-05-13 | $922.00 derived: sum of 3 quarters · filed 2021-05-13 | $1.23K derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | $309.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $617.00 derived: sum of 2 quarters · filed 2021-03-16 | $923.00 derived: sum of 3 quarters · filed 2021-03-16 | $1.23K 10-K · filed 2021-03-16 | |
| 2019-09-30 | $308.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $614.00 derived: sum of 2 quarters · filed 2020-11-10 | $916.00 10-Q · filed 2020-11-10 | $1.22K derived: sum of 4 quarters · filed 2020-11-10 | |
| 2019-06-30 | $306.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $608.00 10-Q · filed 2020-08-13 | $916.00 derived: sum of 3 quarters · filed 2020-08-13 | $1.23K derived: sum of 4 quarters · filed 2020-08-13 | |
| 2019-03-31 | $302.00 10-Q · filed 2020-05-13 | $610.00 derived: sum of 2 quarters · filed 2020-05-13 | $919.00 derived: sum of 3 quarters · filed 2020-05-13 | $1.22K derived: sum of 4 quarters · filed 2020-05-13 | |
| 2018-12-31 | $308.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $617.00 derived: sum of 2 quarters · filed 2020-03-02 | $922.00 derived: sum of 3 quarters · filed 2020-03-02 | $1.22K 10-K · filed 2020-03-02 | |
| 2018-09-30 | $309.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $614.00 derived: sum of 2 quarters · filed 2019-11-12 | $916.00 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $305.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $607.00 10-Q · filed 2019-08-14 | |||
| 2018-03-31 | $302.00 10-Q · filed 2019-05-15 | ||||
| 2017-12-31 | $188.00 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |